Gene mutation characteristics of nonsmall-cell lung carcinoma patients with wild-type epidermal growth factor receptor and sensitivity to Tarceva therapy | Zendy

Daliang Qi | Zendy; Yan Cui | Zendy; Jie Xu | Zendy; Xin Liang | Zendy; Ye Tian | Zendy; Zhongli Zhan | Zendy

Open Access

Gene mutation characteristics of nonsmall-cell lung carcinoma patients with wild-type epidermal growth factor receptor and sensitivity to Tarceva therapy

Author(s) -

Daliang Qi,

Yan Cui,

Jie Xu,

Xin Liang,

Ye Tian,

Zhongli Zhan

Publication year - 2015

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.163847

Subject(s) - kras , epidermal growth factor receptor , neuroblastoma ras viral oncogene homolog , cancer research , hras , pten , medicine , targeted therapy , lung cancer , mutation , wild type , oncology , gene , cancer , biology , colorectal cancer , pi3k/akt/mtor pathway , signal transduction , mutant , genetics

To explore characteristic gene mutations in nonsmall-cell lung carcinoma (NSCLC) patients with wild-type epidermal growth factor receptor (EGFR) and sensitivity to Tarceva therapy; to observe the efficacy and safety of Tarceva therapy for NSCLC patients with wild-type EGFR.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research